Novel exendin agonist compounds

Details for Australian Patent Application No. 2006225304 (hide)

International Classifications

Event Publications

26 October 2006 Application Open to Public Inspection

Published as AU-B-2006225304

26 October 2006 Complete Application Filed

11 January 2007 Section 223 Application Allowed

Amylin Pharmaceuticals, Inc. The time in which to make a further application for a divisional patent has been extended to 22 Oct 2006. Address for service in Australia - Spruson & Ferguson Level 35 St Martins Tower 31 Market Street Sydney NSW 2000

4 December 2008 Application Accepted

Published as AU-B-2006225304

2 April 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.